Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Adv Healthc Mater. 2014 Feb 20;3(7):989–994. doi: 10.1002/adhm.201300532

Scheme 1.

Scheme 1

The concept of conferring immune-inhibitory properties using CD200-coated surfaces. Traditional biomaterials non-specifically adsorb proteins, which activate immune cells. Immunomodulatory biomaterials displaying CD200 will bind to CD200R and activate inhibitory pathways to prevent immune cell activation.